Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting -0.61. At the close of trading, the stock’s price was $2.38, to imply a decrease of -1.24% or -$0.03 in intraday trading. The LYEL share’s 52-week high remains $3.97, putting it -66.81% down since that peak but still an impressive 44.54% since price per share fell to its 52-week low of $1.32. The company has a valuation of $604.76M, with an average of 930.88K shares over the past 3 months.
Lyell Immunopharma Inc (NASDAQ:LYEL) trade information
After registering a -1.24% downside in the last session, Lyell Immunopharma Inc (LYEL) has traded red over the past five days. The stock hit a weekly high of 3.14, dropping -1.24% in its intraday price action. The 5-day price performance for the stock is -2.86%, and 14.42% over 30 days. With these gigs, the year-to-date price performance is 22.68%.
Lyell Immunopharma Inc (LYEL) estimates and forecasts
Looking at statistics comparing Lyell Immunopharma Inc share performance against respective industry, we note that the company has outperformed competitors. Lyell Immunopharma Inc (LYEL) shares are 47.83% up over the last 6 months, with its year-to-date growth rate higher than industry average at 12.90% against 9.70%.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -15.28% for the past 5-year period. While 2024 is set for a 8.52% return in earnings, projections for the next 5 years are at -7.90% annually.
LYEL Dividends
Lyell Immunopharma Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Lyell Immunopharma Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
